Controversies in the surgical management of gastric cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 1, Issue 1, 2003, Pages 115-124

  Kooby, David A ^a   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adjuvant chemotherapy; Gastrectomy; Lymph node excision; Neoplasms; Splenectomy; Stomach

Indexed keywords

GASTRECTOMY; HUMAN; REVIEW; STOMACH TUMOR;

GASTRECTOMY; HUMANS; STOMACH NEOPLASMS;

EID: 0242679904     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2003.0012     Document Type: Article

References (55)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. MacDonald JS, Smalley SR, Benedetti J, et al. Chemo-radiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730.
3. Songun I, Bonenkamp JJ, Hermans J, et al. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32A:433-437.
4. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: Ten-year results of the German gastric cancer study. Ann Surg 1998;228:449-461.
5. McNeer G, Bowden L, Booner RJ, et al. Elective total gastrectomy for cancer of the stomach: End results. Ann Surg 1974;180:252-256.
6. Paolini A, Tosato F, Cassese M, et al. Total gastrectomy in the treatment of adenocarcinoma of the cardia: Review of the results in 73 resected patients. Am J Surg 1986;151:238-243.
7. Butler JA, Dubrow TJ, Trezona T, et al. Total gastrectomy in the treatment of advanced gastric cancer. Am J Surg 1989;158:602-604.
8. Bozzetti F. Total versus subtotal gastrectomy in cancer of the distal stomach: Facts and fantasy. Eur J Surg Oncol 1992; 18:572-579.
9. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: A French prospective controlled study. Ann Surg 1989; 209:162-166.
10. Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220:176-182.
11. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: Five-year survival rates in a multicenter randomized Italian trial. Ann Surg 1999; 230:170-178.
12. Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal-only approach: Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg 1997;225:678-683.
13. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995;180:577-582.
14. Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998; 123:127-130.
15. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1461.
16. Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-868.
17. Wangensteen O, Wangensteen S, Dennis C. History of gastric surgery: Glimpses into its early and more recent past. In: Nyhus L, Wastell C, eds. Surgery of the Stomach and Duodenum. Boston, MA: Little Brown; 1986:8.
18. McNeer G, Sunderland D, Ortega L. A more thorough operation for gastric cancer: Anatomical basis and description of technique. Cancer 1951;4:957-967.
19. Sunderland D, McNeer G, Ortega L. The lymphatic spread of gastric cancer. Cancer 1953;6:987-996.
20. Kodama M, Ishikawa K, Koyama H, et al. Study on the lymphatic flow of the lower gastric region for radical lymphadenectomy in advanced lower gastric cancer. J Jpn Surg Soc 1988;89:1008-1013.
21. Yoshida K, Ohta K, Ohhashi I, et al. Studies on gastric lymphatics by using activated carbon particle (CH44) and lymph node metastasis of gastric cancer. J Jpn Surg Soc 1988; 89:664-670.
22. Kodama Y, Sugimachi K, Soejima K, et al. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981;5:241-248.
23. Maruyama K, Sasako M, Kinoshita T, et al. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 1998;34:1480-1489.
24. Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-217.
25. Degiuli M, Sasako M, Ponzetto A, et al. Extended lymph node dissection for gastric cancer: Results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 1997;23:310-314.
26. Yildirim E, Celen O, Berberoglu U. The Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile? J Am Coll Surg 2001;192:25-37.
27. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: Is location more important than number? An analysis of 1,038 patients. Ann Surg 2000;232:362-371.
28. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988;75:110-112.
29. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-914.
30. Bonenkamp JJ, van de Velde CJ, Sasako M, Hermans J. R2 compared with R1 resection for gastric cancer: Morbidity and mortality in a prospective, randomised trial. Eur J Surg 1992;158:413-418.
31. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC Randomized Surgical Trial. Br J Cancer 1999;79:1522-1530.
32. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. Lancet 1996;347:995-999.
33. Maruyama K. Lymphatic flow of gastric cardia: A study by endoscopic lymphography [abstract]. Stomach Intest 1978;13:1533.
34. Kwon SJ. Prognostic impact of splenectomy on gastric cancer: Results of the Korean Gastric Cancer Study Group. World J Surg 1997;21:837-844.
35. Sugimachi K, Kodama Y, Kumashiro R, et al. Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer. Gann 1980;71:704-709.
36. Sakaguchi T, Sawada H, Yamada Y, et al. Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology 2001;48:603-605.
37. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. I. Clinical classification. Jpn J Surg 1981;11:127-139.
38. Soga J, Kobayashi K, Saito J, et al. The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg 1979;3:701-708.
39. Otsuji E, Yamaguchi T, Sawai K, et al. End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery 1996;120:40-44.
40. Brady MS, Rogatko A, Dent LL, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991;126:359-364.
41. Wanebo HJ, Kennedy BJ, Winchester DP, et al. Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on long-term survival. J Am Coll Surg 1997;185:177-184.
42. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748.
43. Toge T, Hamamoto S, Itagaki E, et al. Analysis of suppressor cell activity in spleen cells from gastric cancer patients and the effect of splenectomy on prognosis of gastric cancer. J Jpn Surg Soc 1983;84:961.
44. Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002;131:401-407.
45. Estape J, Grau JJ, Lcobendas F, et al. Mitomycin C as an adjuvant treatment to resected gastric cancer: A 10-year followup. Ann Surg 1991;213:219-221.
46. Nakajima T, Nashimoto A, Kitamura M, et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomised trial. Lancet 1999;354:273-277.
47. Kim JP, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992;216: 269-278.
48. The Gastrointestinal Tumor Study Group. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. Cancer 1982;49:1116-1122.
49. Engstrom PF, Lavin PT, Douglass HO Jr, Brunner KW. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Cancer 1985;55: 1868-1873.
50. The Italian Gastrointestinal Tumor Study Group. Adjuvant treatments following curative resection for gastric cancer. Br J Surg 1988;75:1100-1104.
51. Coombes RC, Schein PS, Chilvers CE, et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Int J Clin Oncol 1990;8:1362-1369.
52. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up. Lancet 1994;343:1309-1312.
53. Weber SM, Karpeh MS. Randomized clinical trials in gastric cancer. Surg Oncol Clin North Am 2002;11:111-131.
54. Allum WH, Hallissey MT, Ward LC, Hockey MS. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report. Br J Cancer 1989;60:739-744.
55. Kelsen DP, Schwartz G, Janjan N, Minsky B. A randomized phase II comparison of two cisplatin-paclitaxel containing chemoradiation regimens in resected gastric cancers. Radiation Therapy Oncology Group 2001, RTOG G-0114:1-33.